Dooley Audrey, Gao Beirong, Shi-Wen Xu, Abraham David J, Black Carol M, Jacobs Michael, Bruckdorfer K Richard
Department of Biochemistry and Molecular Biology, Royal Free and University College Medical School, London NW3 2PF, UK.
Free Radic Biol Med. 2007 Jul 15;43(2):253-64. doi: 10.1016/j.freeradbiomed.2007.04.017. Epub 2007 Apr 29.
Nitric oxide ((.-)NO) is an important physiological signaling molecule and potent vasodilator. Recently, we have shown abnormal (.-)NO metabolism in the plasma of patients with systemic sclerosis (SSc), a disease that features excessive collagen overproduction as well as vascular dysfunction. The current study investigates the effects of (.-)NO and peroxynitrite (ONOO(-)) on secretion of type I collagen by SSc dermal fibroblasts, compared with those from normal dermal fibroblasts (CON) and a dermal fibroblast cell line (AG). Dermal fibroblasts were incubated with (.-)NO donors (SNP, DETA-NONOate) with or without the antioxidant ascorbic acid, or ONOO(-) for 24-72 h. In CON and AG fibroblasts, type I collagen was dose dependently decreased by SNP or DETA-NONOate. However, (.-)NO had no effect in SSc fibroblasts. Furthermore, the inhibition of collagen synthesis by (.-)NO was reversed by ascorbic acid and was not affected by 1H-[1,2,4]oxadiazole[4,3-a]quinoxalin-1-one, an inhibitor of soluble guanyl cyclase, or 8-bromoguanosine cyclic 3',5'-monophosphate, a cGMP agonist. SNP also showed a significant up-regulation of matrix metalloproteinase-1 (MMP-1) protein and activity levels, an essential collagenase involved in collagen degradation, in the AG fibroblasts. Additionally, (.-)NO-treated fibroblasts had lower prolyl hydroxylase activity, an enzyme important in the post-translational processing of collagen, while there was no effect on total protein levels. There were no significant effects on type I collagen levels when dermal fibroblasts were treated with ONOO(-). Taken together, ()NO inhibits collagen secretion in normal dermal fibroblasts but regulation is lost in SSc fibroblasts, while ONOO(-) itself is ineffective. (.-)NO inhibition of collagen was by cGMP-independent regulatory mechanisms and in part may be due to up-regulation of MMP-1 and/or inhibition of prolyl hydroxylase. These differences may contribute to the observed pathology of SSc.
一氧化氮(·NO)是一种重要的生理信号分子和强效血管舒张剂。最近,我们发现系统性硬化症(SSc)患者血浆中存在异常的·NO代谢,SSc是一种以胶原蛋白过度产生以及血管功能障碍为特征的疾病。本研究调查了·NO和过氧亚硝酸盐(ONOO⁻)对SSc真皮成纤维细胞分泌I型胶原蛋白的影响,并与正常真皮成纤维细胞(CON)和一种真皮成纤维细胞系(AG)进行比较。将真皮成纤维细胞与·NO供体(SNP、DETA-NO)在有或没有抗氧化剂抗坏血酸的情况下孵育,或与ONOO⁻孵育24至72小时。在CON和AG成纤维细胞中,SNP或DETA-NO可使I型胶原蛋白呈剂量依赖性减少。然而,·NO对SSc成纤维细胞没有影响。此外,抗坏血酸可逆转·NO对胶原蛋白合成的抑制作用,且该抑制作用不受可溶性鸟苷酸环化酶抑制剂1H-[1,2,4]恶二唑[4,3-a]喹喔啉-1-酮或cGMP激动剂8-溴鸟苷环3',5'-单磷酸的影响。SNP还使AG成纤维细胞中基质金属蛋白酶-1(MMP-1)的蛋白和活性水平显著上调,MMP-1是参与胶原蛋白降解的一种重要胶原酶。此外,经·NO处理的成纤维细胞脯氨酰羟化酶活性较低,脯氨酰羟化酶是胶原蛋白翻译后加工过程中的一种重要酶,而对总蛋白水平没有影响。用ONOO⁻处理真皮成纤维细胞时,对I型胶原蛋白水平没有显著影响。综上所述,·NO可抑制正常真皮成纤维细胞中的胶原蛋白分泌,但在SSc成纤维细胞中这种调节作用丧失,而ONOO⁻本身无效。·NO对胶原蛋白的抑制作用是通过不依赖cGMP的调节机制,部分可能是由于MMP-1的上调和/或脯氨酰羟化酶的抑制。这些差异可能导致了观察到的SSc病理变化。